Editor’s Choice: Lunchbox Trial

Listen to Gynecologic Oncology
10 min
Editor’s Choice: Lunchbox Trial

Listen "Editor’s Choice: Lunchbox Trial"

Descargar episodio Ver en sitio original

Episode Synopsis

Editor’s Choice Paper: Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma Editorial:What's in your “lunchbox”? Sandwich versus sequential chemotherapy and irradiation for advanced endometrial cancerHosted by:Ursula Matulonis, MD, Associate Editor of Gynecologic OncologyFeaturing:Joyce Barlin, MD, Women’s Cancer Care Associates & Albany Medical CollegeGretchen Glaser, MD, Mayo Clinic John Weroha, MD, Mayo Clinic

More episodes of the podcast Listen to Gynecologic Oncology

Navigating Surgical Complexity After Ovarian Cancer Neoadjuvant Chemotherapy 05/11/2025
Cervical Cancer Care in Focus: Consensus on Quality, Equity, and Radiation Therapy 29/09/2025
Beyond Anesthesia: Self-Hypnosis in ERAS Programs 29/08/2025
To divert or not to divert: that is the question 08/07/2025
Carcinosarcoma Wars: A New Hope for TROP-2 Therapeutic Targeting 14/07/2025
Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer
Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study 03/03/2025
Clinical trials: Panacea or pitfall 27/01/2025
FOLR1 status: Landscape beyond high grade serous ovarian cancer 01/01/2025
Benefits of hormonal therapy for low grade serous ovarian cancer 01/01/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA